Back to results
US 10,500,238 B2Granted
Use of gram negative species to treat atopic dermatitis
AssigneeThe United States of America, as represented by the Secretary, Department of Health and Human Services
InventorsIan Antheni Myles, Sandip K. Datta
Life of this patent
Estimating the term…
Abstract
Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable Gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
Claims19
A method for treatment of atopic dermatitis, comprising:
- topically administering to a subject in need thereof a pharmaceutical composition comprising at least one strain of Roseomonas mucosa, wherein the at least one strain of Roseomonas mucosa comprises a nucleic acid sequence selected from the group consisting of SEQ ID NO:
- 1, SEQ ID NO:
- 2, and SEQ ID NO:
- 3, and wherein the at least one strain of Roseomonas mucosa is present in an amount sufficient for treatment of atopic dermatitis in the subject.
1 more element
Dependencies are inferred from the claim text.